Related references
Note: Only part of the references are listed.Endovascular thrombectomy without versus with intravenous thrombolysis in acute ischemic stroke: a non-inferiority meta-analysis of randomized clinical trials
Chun-Hsien Lin et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2022)
IV tPA is associated with increase in rates of intracerebral hemorrhage and length of stay in patients with acute stroke treated with endovascular treatment within 4.5 hours: should we bypass IV tPA in large vessel occlusion?
Ameer E. Hassan et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2021)
Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial
Wenjie Zi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial
Kentaro Suzuki et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions
Sandra Lopes et al.
PHARMACOECONOMICS (2020)
Mechanical Thrombectomy in Acute Ischemic Stroke Patients Performed Within and Outside Clinical Trials in the United States
Adnan I. Qureshi et al.
NEUROSURGERY (2020)
The use of micro-costing in economic analyses of surgical interventions: a systematic review
Shelley Potter et al.
HEALTH ECONOMICS REVIEW (2020)
Direct mechanical thrombectomy in tPA-ineligible and -eligible patients versus the bridging approach: a meta-analysis
Johannes Kaesmacher et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2019)
Pre-thrombectomy intravenous thrombolytics are associated with increased hospital bills without improved outcomes compared with mechanical thrombectomy alone
Ameer E. Hassan et al.
JOURNAL OF NEUROINTERVENTIONAL SURGERY (2019)
Cost-effectiveness analysis of mechanical thrombectomy plus tissue-type plasminogen activator compared with tissue-type plasminogen activator alone for acute ischemic stroke in France
N. Kabore et al.
REVUE NEUROLOGIQUE (2019)
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
William J. Powers et al.
STROKE (2018)
Real-world costs of ischemic stroke by discharge status
F. Mu et al.
CURRENT MEDICAL RESEARCH AND OPINION (2017)
Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke: Results From the SWIFT-PRIME Trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke)
Theresa I. Shireman et al.
STROKE (2017)
External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting
Martine Hoogendoorn et al.
VALUE IN HEALTH (2017)
Two Paradigms for Endovascular Thrombectomy After Intravenous Thrombolysis for Acute Ischemic Stroke
Gaspard Gerschenfeld et al.
JAMA NEUROLOGY (2017)
Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial
Bijoy K. Menon et al.
CIRCULATION (2016)
Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke
Jeban Ganesalingam et al.
STROKE (2015)
Cost-Effectiveness of Intra-Arterial Treatment as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Ischemic Stroke
Michelle H. Leppert et al.
STROKE (2015)
Evaluation of Interval Times From Onset to Reperfusion in Patients Undergoing Endovascular Therapy in the Interventional Management of Stroke III Trial
Mayank Goyal et al.
CIRCULATION (2014)
Cost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke Current Evidence
Denise M. Boudreau et al.
STROKE (2014)
Discharge Destination as a Surrogate for Modified Rankin Scale Defined Outcomes at 3-and 12-Months Poststroke Among Stroke Survivors
Adnan I. Qureshi et al.
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION (2012)
Cost-effectiveness of carotid artery stent placement versus endarterectomy in patients with carotid artery stenosis Clinical article
Asif A. Khan et al.
JOURNAL OF NEUROSURGERY (2012)
Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7
David M. Eddy et al.
MEDICAL DECISION MAKING (2012)
National Trends in Utilization and Outcomes of Endovascular Treatment of Acute Ischemic Stroke Patients in the Mechanical Thrombectomy Era
Ameer E. Hassan et al.
STROKE (2012)
Drip-and-Ship Thrombolytic Treatment Paradigm Among Acute Ischemic Stroke Patients in the United States
Wondwossen G. Tekle et al.
STROKE (2012)
Cost-Effectiveness of Tissue-Type Plasminogen Activator in the 3-to 4.5-Hour Time Window for Acute Ischemic Stroke
Christie E. Tung et al.
STROKE (2011)
A Cost-Utility Analysis of Mechanical Thrombectomy as an Adjunct to Intravenous Tissue-Type Plasminogen Activator for Acute Large-Vessel Ischemic Stroke
Anthony S. Kim et al.
STROKE (2011)
Cost-effectiveness analysis of endovascular versus neurosurgical treatment for ruptured intracranial aneurysms in the United States
Alberto Maud et al.
JOURNAL OF NEUROSURGERY (2009)
Outcomes validity and reliability of the modified Rankin scale: Implications for stroke clinical trials - A literature review and synthesis
Jamie L. Banks et al.
STROKE (2007)
International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial
A Molyneux et al.
LANCET (2002)
Share Paper
